Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients

BACKGROUND: Approximately 60% of patients with colorectal cancer (CRC) undergo either local recurrence or distant metastases after surgery. Current prognostic biomarkers are insufficient to predict recurrence of CRC and provide little forecast information about what patients are likely to receive be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Dengbo, Qiao, Meng, Yao, Yunfeng, Li, Ming, Chen, Hailong, Dong, Qi, Jia, Jinying, Cui, Xinxin, Li, Zhaowei, Xia, Jinhong, Gu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156709/
https://www.ncbi.nlm.nih.gov/pubmed/30166271
http://dx.doi.org/10.1016/j.ebiom.2018.08.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156709/
https://www.ncbi.nlm.nih.gov/pubmed/30166271
http://dx.doi.org/10.1016/j.ebiom.2018.08.042

Ejemplares similares